Dementia

Interventions to protect or improve auditory health across the lifespan could be a cost-effective means of slowing the rapid rise of dementia in the US, authors wrote.

Your daily dose of the clinical news you may have missed.

Higher levels of cardiovascular health were associated with lower levels of neurofilament light chain across age, sex, race/ethnicity, and Alzheimer disease risk.

Your daily dose of the clinical news you may have missed.

Vesper Bio anticipates completing enrollment and dosing by mid-2025 in the Phase 1B/2A trial for VES001.

The effective approach to identifying risk for the disruptive cognitive issues holds promise for development of early intervention to mitigate decline.